SPOTLIGHT -
Dr. Tabbara on Treatment for Transplant-Eligible and -Ineligible Patients With Multiple Myeloma
Imad Tabbara, MD, discusses available treatment options for transplant-eligible and -ineligible patients with multiple myeloma.
Read More
Dr. Tabbara on the Expansion of Treatment Options for AML
Imad Tabbara, MD, discusses the expansion of treatment options for patients with acute myeloid leukemia.
Up-Front Osimertinib Provides Comparable OS, Improved Brain PFS Vs Sequential Gefitinib/Osimertinib in EGFR+ NSCLC
Dr Nasioudis on the Use of NGS to Identify the Molecular Profile of Endometroid Ovarian Cancer
Dr Buckingham on the Use of Patient-reported Outcomes to Predict Frailty in Patients With Ovarian Cancer
Dr Slomovitz on the Investigation of Letrozole Plus Ribociclib in Low-Grade Serous Ovarian Carcinoma
